InvestorsHub Logo
Post# of 596859
Next 10
Followers 107
Posts 26420
Boards Moderated 0
Alias Born 02/01/2009

Re: None

Monday, 03/30/2015 11:05:59 AM

Monday, March 30, 2015 11:05:59 AM

Post# of 596859
BICX While some patients do well with the oral formulation, there is a drawback that it must be taken daily and a patient whose craving becomes overwhelming can obtain the euphoria simply by skipping a dose before resuming abuse. Patients who received the program developed by BioCorRx are treated with a slow release dose that can last up to year in many patients (depending on various factors such as metabolism rates), which gives the patients a higher success rate for the treatment of alcoholism.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.